The role of the mitochondrial Ca 2+ uniporter (MCU) in physiologic cell proliferation remains to be defined. Here, we demonstrated that the MCU was required to match mitochondrial function to metabolic demands during the cell cycle. During the G 1 -S transition (the cycle phase with the highest mitochondrial ATP output), mitochondrial fusion, oxygen consumption, and Ca 2+ uptake increased in wild-type cells but not in cells lacking MCU. In proliferating wild-type control cells, the addition of the growth factors promoted the activation of the Ca 2+ /calmodulindependent kinase II (CaMKII) and the phosphorylation of the mitochondrial fission factor Drp1 at Ser
INTRODUCTION
The mitochondrial Ca 2+ uniporter (MCU) is a highly conserved protein of the inner mitochondrial membrane that mediates the electropho retic Ca 2+ uptake into the mitochondrial matrix (1, 2) . MCU dependent Ca 2+ uptake increases tricarboxylic acid cycle activity by activating Ca 2+ dependent hydrogenases (3) . Accordingly, MCU deficiency in cardiac muscle prevents the adaptation of energy supply to states of maximal demand (4) . However, the role of MCU in less meta bolically demanding physiologic processes such as cell proliferation remains unclear (5) .
During the cell cycle, fluctuations in intracellular Ca 2+ levels and transients occur (6) and drive the periodic activation of Ca /CaM dependent kinases (CaMK), and the phosphatase calcineurin (7, 8) . Inhibition of mitochondrial Ca 2+ uptake in proliferating smooth muscle cells disturbs cytosolic Ca 2+ transients (9, 10) . In a pancreatic  cell line, increased mitochondrial Ca 2+ concentration in S and G 2 M phases is associated with dynamic changes in cytosolic Ca 2+ (11) . Thus, because mitochondrial Ca 2+ uptake contributes to the fluctu ations in Ca 2+ compartmentalization throughout the cell cycle (11) , MCU may represent a fundamental but underappreciated regula tor of cell cycle progression. MCU −/− mice at all ages have relatively lower body and organ weight compared to their wildtype (WT) littermates, providing indirect evidence for a role of MCU in cell proliferation (12) .
Dynamic changes in mitochondrial morphology promote early cell cycle progression (13) , with mitochondria converting from a highly fragmented state in G 0 to a hyperfused network at G 1 S transition. This event correlates with the high mitochondrial adenosine 5′ triphosphate (ATP) output in cells that are otherwise predomi nantly dependent on glycolysis (13) . The Ca 2+ dependent proliferation effectors CaMKI, CaMKII and cyclindependent kinase 1 (CDK1), and calcineurin regulate mitochondrial fission mediated by the gua nosine triphosphatase (GTPase) dynamin related protein 1 (Drp1) (14) (15) (16) (17) (18) . Altered cytosolic Ca 2+ levels caused by decreased Ca 2+ mito chondrial uptake are thus expected to promote fission mediated by Drp1, providing a potential mechanistic link for MCUdependent proliferation. Here, we hypothesized that cell cycle progression re quires coordination of mitochondrial and cytosolic Ca 2+ levels and that MCU deficiency impairs cell proliferation by altering cytoplasmic Ca 2+ transients, mitochondrial dynamics due to altered Drp1 phos phorylation, and mitochondrial energetics.
RESULTS

MCU deficiency decreases cell proliferation in vivo and in vitro
Wound closure after cutaneous punch biopsy was significantly de layed in MCU −/− mice, with a 60% reduction in wound size compared to 85% in littermate WT mice on day 10 after injury ( Fig. 1, A and B) . We also determined the area and number of cell nuclei in the aorta, an organ with limited postnatal proliferation, to test for develop mental differences (Fig. 1, C to E). Hematoxylin and eosin (H&E) staining of aortic cross sections from 12weekold mice demonstrated a significant reduction in the area and number of nuclei in the medial layer in MCU −/− mice compared to WT littermates. The ratio of cells to area was similar in both genotypes, suggesting that the difference in size was at least partially driven by reduced cell numbers (Fig. 1F) . To assess postnatal physiological organ regeneration, we labeled pro liferating hepatocytes by proliferating cell nuclear antigen (PCNA) immunostaining. Significantly fewer PCNApositive cells were de tected in liver sections from MCU −/− mice (fig. S1, A and B). Together, these results implicate MCU as a regulator of cell proliferation. More over, as reported previously (12) , male and female MCU −/− mice were significantly smaller than their WT littermates on postnatal days 18, 21, and 33 (fig. S1, C to E). Although the weights of the spleen, heart, and kidney were significantly reduced in MCU −/− mice, the organ weight adjusted to total body weight was not different between genotypes, supporting a general effect of MCU deletion on organ development and growth (fig. S1, F to H).
Acute silencing of MCU by small interfering RNA (siRNA) or pharmacological inhibition with RU360 significantly reduced the number of WT vascular smooth muscle cells (VSMCs) in vitro at 72 hours after treatment with plateletderived growth factor (PDGF; Fig. 1 , G and H), findings that were confirmed by cell counts of cultured skin fibroblasts from MCU −/− and WT mice (Fig. 1I) . MCU inhibition reduces apoptotic cell death, making it unlikely that the detected differences in cell numbers re sult from increased apoptosis (12, 19) . This notion was confirmed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end la beling (TUNEL) staining of VSMCs with MCU knockdown (Fig. 1J) . Together, these data support that MCU deficiency reduces cell proliferation in fibroblasts and dedifferentiated smooth muscle cells. (Fig. 2 , A to C), suggesting higher peak concen trations and impaired clearance. The up take of mitochondrial Ca 2+ and its release after application of carbonyl cyanide ptrifluoromethoxyphenylhydrazone (FCCP) were reduced in MCU −/− skin fibroblasts (Fig. 2D) . To determine endo plasmic reticulum (ER) Ca 2+ content, we treated WT and MCU −/− skin fibro blasts with the sarcoplasmic reticulum Ca 2+ adenosine triphosphatase (SERCA) inhibitor thapsigargin. The cytoplasmic Ca 2+ transients in MCU −/− VSMCs were prolonged compared to WT (Fig. 2, E and F) . The Fura2 AM signal at baseline was similar between genotypes (Fig. 2G) . Last, we recorded the cyto plasmic Ca 2+ levels after PDGF administration over 50 min (3000 s; Fig. 2H ). After the initial treatment, the cytosolic Ca 2+ levels returned to baseline in WT but not in MCU −/− VSMCs in which the repeated addition of PDGF further increased cytoplasmic Ca 2+ levels. These data demonstrate that MCU inhibition prolongs cytosolic Ca 2+ tran sients after PDGF treatment in VSMCs.
MCU inhibition prolongs cytosolic
MCU is required to adapt mitochondrial ATP production to energy demands during the cell cycle We next sought to determine how MCU deletion affects cell cycle progression and analyzed WT or MCU −/− fibroblasts in growth arrest and at 16 and 24 hours after release from arrest. At 16 hours, 41% of WT fibroblasts had entered S phase compared to 18% of MCU −/− cells (Fig. 3, A and B) , and cyclin D and E protein abundance signifi cantly increased in WT but not in MCU −/− fibroblasts (Fig. 3 , C to E). To corroborate that MCU deletion impaired Sphase entry, cells were . n = 9 independent experiments. (H) Cell counts for VSMCs treated with the MCU inhibitor RU360 (100 nM) and/or PDGF. n = 8 independent experiments. (I) Cell counts for skin fibroblasts from MCU −/− or WT mice at 72 hours in growth medium with PDGF (20 ng/ml). n = 7 independent experiments. (J) TUNEL staining in VSMCs transfected with MCU or scrambled siRNA and treated with PDGF (20 ng/ml) for 48 hours. n = 6 independent experiments. *P < 0.05, **P < 0.001 by two-way repeated measures analysis of variance (ANOVA) (B), Mann-Whitney U test (D, F, and I), two-tailed t test (E), one-way ANOVA at 48 hours (G and H), and Kruskal-Wallis test (J).
arrested at the G 1 S transition by incubation with aphidicolin, an inhibitor of DNA polymerases. At 5 hours after removal of aphidicolin, significantly more WT than MCU −/− fibroblasts had entered S phase (Fig. 3, F and G) . We also confirmed these findings by assessing the cell cycle progression in WT and MCU −/− VSMCs ( fig. S3, A and B) . Mitochondrial fusion occurs at the G 1 S transition (13) , and progres sion to S phase correlates with greater mitochondrial ATP produc tion (11) . As anticipated, mitochondria were predominantly fragmented in growtharrested WT and MCU −/− fibroblasts (Fig. 3, H and I ). Whereas mitochondria in WT fibroblasts elongated within 16 hours of exposure to growth factors, mitochondria in MCU −/− fibroblasts remained mostly fragmented.
Next, we investigated how MCU deletion affects cytosolic Ca 2+ levels and mitochondrial respiration. Cytosolic Ca 2+ concentrations were significantly increased in WT fibroblasts at 16 hours after re lease from growth arrest but not in MCU −/− fibroblasts (Fig. 4A) . Moreover, WT cells showed that mitochondrial Ca 2+ uptake increased 16 hours after release from growth arrest in parallel with a rise in oxygen consumption rate (OCR), but these changes did not occur in MCU −/− cells (Fig. 4 , B and C). Because mitochondrial fusion promotes mitochondrial Ca 2+ uptake that fuels oxidative phospho rylation and mitochondrial ATP production (13) , our data suggest that MCU is required to adapt mitochondrial ATP production to energy demands during the cell cycle. To test whether the expres sion of proteins in the MCU complex changes during the cell cycle, we performed immunoblots in mitochondria of WT and MCU −/− fibroblasts at 16 and 24 hours after release from cell cycle arrest (Fig. 4D) . The pro tein levels of the regulatory subunits mito chondrial calcium uniporter dominant negative beta subunit (MCUB) and es sential MCU regulator (EMRE) at 16 hours were reduced compared to those at 0 and 24 hours, and the levels of Na+/Ca 2+ /Li+ exchanger (NCLX) and mitochondrial calcium uptake 1 protein (MICU1) at 16 hours were lower than those at 0 hours (Fig. 4, F to H) . MCU deletion led to loss of EMRE, reduced levels of NCLX, and attenuated the changes throughout the cell cycle (Fig. 4D) . These data suggest that the dynamic regulation of the MCU com plex during the cell cycle leads to increased mitochondrial Ca 2+ uptake in S phase in parallel to mitochondrial fusion and in creased mitochondrial respiration.
MCU affects mitochondrial dynamics
Mitochondrial fission and fusion are con trolled by GTPases, including Drp1, a key regulator of mitochondrial fission at the outer mitochondrial membrane (20) . Drp1 is regulated by phosphorylation, which is partially controlled by Ca 2+ dependent signaling (14) (15) (16) . The phosphorylation of Drp1 at Ser 616 promotes mitochondrial fragmentation (18) . Because we detected mitochondrial fission in MCUinhibited cells, we hypothesized that these findings were due to increased Drp1 phosphorylation. As anticipated, acute PDGF treatment induced Drp1 phosphorylation at Ser 616 in proliferating WT VSMCs (Fig. 5 , A and B). However, VSMCs with MCU knockdown displayed high baseline Drp1 phosphorylation that did not further increase with PDGF. Ac cordingly, mitochondrial fission was induced by PDGF in prolifer ating control cells but not in VSMCs with MCU knockdown that displayed fragmented mitochondria at baseline ( fig. S4, A and B) . These findings were recapitulated in vivo. Baseline Drp1 phospho rylation was significantly higher in the heart and aorta of MCU −/− mice (Fig. 5, C and D) . Once activated, Drp1 associates with the outer mitochondrial membrane (16) . Accordingly, at baseline, significantly more Drp1 associated with mitochondria in MCU knockdown cells than in WT cells (Fig. 5, E and F) . In response to PDGF, colocaliza tion of Drp1 with mitochondria increased in WT cells but not in MCUdeficient cells.
Drp1 and its phosphorylation by CaMKII are required to inhibit proliferation in MCU-deficient cells
To dissect whether Drp1 regulates the proliferation defect in MCU −/− cells, we used Drp1 −/− fibroblasts with MCU knockdown or overex pression. Drp1 deletion alone significantly reduced the number of proliferating cells; however, gain or loss of MCU expression did not affect cell numbers beyond those observed after Drp1 knockout (Fig. 5, G to I ). These data demonstrate that the presence of Drp1 is required for the effects of MCU on cell proliferation. Several kinases including protein kinase C (PKC), CDK1, and CaMKII promote the phosphoryla tion of Drp1 at Ser 616 (14) (15) (16) 21) . 
MCU is necessary to maintain mitochondrial reserve capacity in VSMCs
Mitochondrial Ca 2+ uptake through MCU fuels electron transport chain protein ac tivity and is necessary to maintain mito chondrial reserve capacity in cardiac myocytes (12) . We tested whether this is also true in proliferating VSMCs. First, we established that baseline and reserve respiration and extracellular acidification rate (ECAR) were impaired in MCU −/− cells under growth conditions ( VSMCs but not in WT cells (Fig. 7, D to G) . Last, we established that cytosolic CaMKII inhibition restored proliferation of MCUdeficient VSMCs while decreasing proliferation in WT cells (Fig. 7H) .
Inhibition of PKC by Go6083 had no effect on respiration in both genotypes ( fig. S7, A and B) . Because we used cells with a constitu tive MCU deletion, these findings could be due to adaptation to con stitutive MCU deletion as opposed to MCU deficiency. Thus, we also S9, E and F) . To test whether the inhibitory effect of MCU deletion on mitochondrial respiration was due to exaggerated mito chondrial fragmentation, we blocked mitochondrial fission with the Drp1 inhibitor peptide P110. P110 specifically inhibits the interac tion of Drp1 with Fis1 (23). P110 delivery improved mitochondrial respiration in MCU −/− VSMCs after PDGF treatment and restored mitochondrial fusion at baseline and fission in response to PDGF (Fig. 8, A to D) . The inhibition of mitochondrial fission also increased mitochondrial Ca 2+ uptake in WT and MCU −/− cells (Fig. 8E) . In WT VSMCs, overexpression of a constitutively active mutant of CaMKII (CaMKII T287D) induced mitochondrial fission and abrogated fur ther fragmentation by PDGF, whereas P110 pretreatment of WT cells abrogated fission by PDGF (Fig. 8F) . When overexpression of constitutively active CaMKII and Drp1 inhibition with P110 were combined, increased mitochondrial fusion at baseline and increased fission after PDGF treatment were observed, substantiating that cy tosolic CaMKII is upstream of endogenous Drp1 and enhances mito chondrial fission through Drp1.
Overexpression of mitochondrial dynaminlike GTPase (OPA1) and mitofusin 1 and 2 (MFN1/2), which drive mitochondrial fusion at the inner and outer mitochondrial membranes, increased the mito chondrial form factor at baseline in WT and MCU −/− VSMCs. How ever, in contrast to the DRP1 inhibitor P110, OPA1 and MFN1/2 overexpression in MCU −/− VSMCs did not recover mitochondrial fission after PDGF treatment (Fig. 8, G to I) , corroborating that the effects of MCU deletion are through Drp1 activation (Fig. 8J) .
DISCUSSION
Here, we demonstrated that MCU deficiency inhibited proliferation in wound healing, organ development, and postnatal tissue homeo stasis in vivo and of smooth muscle and fibroblasts in vitro. In MCUdeficient cells, cell cycle progression was delayed at the G 1 S transition, a stage in WT cells characterized by mitochondrial fusion and increased mitochondrial Ca 2+ uptake. MCU deficiency delayed cytosolic Ca 2+ clearance after ER Ca 2+ release, increased activation of CaMKII, Drp1 phosphorylation at Ser 616 , mitochondrial fission, impaired mitochondrial respiration and glycolysis, and cell prolif eration. Mitochondrial OCR and cell proliferation were restored by either MCU overexpression or inhibition of mitochondrial fission or of cytosolic CaMKII in MCUdeficient cells but not in WT cells. Thus, we posit that Drp1 phosphorylation occurs physiologically in response to growth factor treatment of WT cells secondary to tran sient activation of CaMKII. When MCU is absent, constitutive acti vation of CaMKII promotes constitutive fission, which prevents a subsequent fusion event that is required for cell cycle progression (Fig. 8J) . By controlling cytosolic Ca 2+ transients and Ca 2+ dependent signaling mediated by CaMKII, MCU regulates mitochondrial dynamics in G 1 S phase and respiration necessary for cell cycle progression. Although the decreased body weight of MCU −/− mice suggests impaired cell proliferation (12) , current data on MCU as a regulator of cell proliferation are limited to cancer cell lines. MCU expression has been positively correlated with poor prognosis, tumor cell mi gration, invasion, and resistance to apoptosis but not to cell prolif eration (24) (25) (26) (27) . These results may not adequately represent Ca 2+ regulation during cell proliferation in nonmalignant cells because oncogene activation alters relevant Ca 2+ signaling (28) . Changes in the expression or function of Orai3 in breast cancer (29) and of SERCA in prostate cancer (30) imply that cytosolic Ca 2+ fluxes are altered at various points during the cell cycle. Nonetheless, inhibition of the LETM1 (leucine zipper/EF hand-containing transmembrane1 pro tein), which promotes mitochondrial Ca 2+ influx and efflux, impaired fibroblasts proliferation, although the underlying mechanism remains unclear (31) .
At G 1 S transition, mitochondria are hyperfused and have increased capacity to take up Ca 2+ through MCU (6, 11, 13) . Here, we demonstrated that MCU was required to maintain cell cycle progression, cytosolic Ca 2+ clearance, and mitochon drial hyperfusion during G 1 S phase (Figs. 3, A, B, H, and I, and 4, A and B) . The mechanisms behind mitochondrial hyperfusion in G 1 S transition (13) clearance was delayed after growth factor application over a prolonged time period (Fig. 2H ). Minor differences in baseline cytoplasmic Ca 2+ levels were seen as pre viously reported (10) . The delayed cytosolic Ca 2+ clearance without increased base line levels may be sufficient to sustain CaMKII activity and Drp1 Ser 616 phos phorylation. CaMKII has been identified as cell cycle promoter, for example, by activating CDC25 in G 2 phase (33) . CaMKII inhibition in MCUdeficient cells restored PDGFdependent Drp1 phospho rylation. We posit that this occurs through activation of other kinases that target Drp1 Ser 616 , such as Erk1/2 (extracellular signal-regulated kinases 1 and 2), CDK1, or the Ca 2+ independent PKC isoform  (PKC) (17) . Moreover, mitochondrial OCR increased with CaMKII inhibition even in the absence of MCU, consistent with reports of higher mitochondrial crista number and ATP synthesis activity in cells with hyperfused, tubular mitochondria (34, 35) . By contrast, PKC inhibition or overexpression of Opa1 and Mfn1/2 did not rescue metabolism or mitochondrial dynamics in MCUdeficient cells ( Fig. 8H and fig. S7 , A and B), supporting that mitochondrial fission and its downstream effects are indeed driven by altered cytosolic Ca 2+ levels. Although numerous cytosolic regulators of mitochondrial dynamics during mitosis have been identified, our data imply that mitochondria through MCUdependent Ca 2+ influx modulate mitochondrial fission and thereby cell proliferation. The MCU complex subunits MICU, EMRE, and MCUB regulate MCU activity (36) (37) (38) , and the complex composition determines the diverse MCU activity in different tissues (39) . In our experiments, we detected evidence for changes in MCU subunit composition that coincided with increased mitochondrial Ca 2+ uptake in G 1 S phase. In particular, the MCU regulator MCUB (37) and the subunit EMRE, which is required for opening of the MCU pore and its tight regulation (40, 41) , as well as MICU1 (42), were affected. Thus, it is tempting to speculate that acute changes in MCU subunit composition or activity during the cell cycle affect mitochondrial Ca 2+ uptake, which positions the MCU complex as an active regulator of cell cycle progression and cell proliferation. Further experiments to ascertain the complex composition in the inner mitochondrial membrane and investigations into the regulation of these events will be necessary to corroborate the role of the MCU complex in this context. 
MATERIALS AND METHODS
Animals
All animal procedures were approved by the University of Iowa Institutional Animal Care and Use Committee protocol. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Na tional Institutes of Health (NIH). We used 10 to 16weekold male and female MCU −/− mice, a gift from T. Finkel, NIH, in CD1 back ground and littermate controls on regular chow (7913, Teklad) for all in vivo experiments. The body weight in MCU −/− mice and their littermates was determined on postnatal days 7, 18, 21, and 28 and before euthanasia. Weights of the heart, liver, and kidneys were obtained after euthanasia and expressed as ratios of organ to body weight.
Skin wounding
Mice were anesthetized with isoflurane. To create fullthickness skin wounds, mice were shaved, and surgical scrub was performed at the surgical site. A sterile 6mm biopsy punch was placed on the back, and a punch of dorsalrostral back skin and panniculus carnosus was excised. Care was taken not to injure underlying muscles. Digital photographs were acquired on the day of surgery and every day thereafter. The wound margins were traced in ImageJ to calculate the wound area (43) .
Histology and sectioning
The aortas and livers from 12weekold MCU −/− and WT litter mates were fixed in 4% paraformaldehyde and embedded in paraffin. Fivemicrometer sections of the aorta and liver were collected on SuperFrost Plus slides. H&E staining was performed on sections of the distal thoracic aorta. Deparaffinized liver sections were washed with phosphatebuffered saline (PBS) and permeabilized with 0.1% Triton X100 solution for 10 min at room temperature and blocked with the Vector MouseonMouse (MOM) Detection Kit (Vector Laboratories). AntiPCNA primary antibody was applied for 1 hour at room temperature. Sections were washed with PBS before appli cation of an horseradish peroxidase (HRP)-conjugated secondary antibody for 30 min. 3,3′Diaminobenzidine was then applied for 10 min. Last, the sections were counterstained with Harris hema toxylin for 10 s.
Cell isolation and culture
Mouse aortic VSMCs were isolated from male and female mice by enzymatic dispersion (44) . Cells were cultured in lowglucose (1 mM) Dulbecco's modified Eagle's medium (DMEM) with pyruvate supplemented with 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), 8 mM Hepes, MEM vitamins, and nonessential amino acids at 37°C in a humidified 95% air and 5% CO 2 incubator. Passagematched mouse VSMCs from 5 to 10 passages were used for all experiments. Skin fibroblasts were isolated from 1weekold male and female MCU −/− and WT littermate mouse pups. (45) . After removal of the epidermis, the dermis was cut into small pieces under sterile condi tions and digested overnight in DMEM with Fungizone and antibiotics with collagenase type I (300 U/ml). The following day, the digested material was dispersed by vigorous pipetting and centrifuged at 1200 rpm for 5 min. The pelleted cells were plated in DMEM sup plemented with 10% FBS, penicillin/streptomycin, and Fungizone (2.5 g/ml). Cells from passages 1 to 5 were used.
siRNA transfection
Five hundred thousand VSMCs were seeded in a T75 flask overnight. The next day, siRNA duplexes for MCU (5′CGACCUAGAGAAAUA CAAUCAGCTC3′ and 5′ GGGAAUAAAGGGAUCU UAAAUGCTG3′ at a ratio of 1:1) or scramble control (5′CGUUAAUCGCGU AUAAUACGCGUA3′; Integrated DNA Technologies) were transfected (5 nM in 20 l of DharmaFECT 4 reagent). Knockdown efficiency was determined after 72 hours by Western blotting for MCU, which was normalized to COXIV signal. The knockdown efficiency was con sistently greater than 75%.
Cell counting
VSMCs and skin fibroblasts were cultured in 12well plates at 5000 cells per well in 2 ml DMEM containing 10% FBS. Twentyfour hours after plating, cells were treated with PDGF (20 ng/ml). RU360 (100 nM) was added with PDGF to some wells. After 24 to 72 hours, cells were trypsinized and counted in triplicate using a Beckman Coulter Z1 cell counter.
TUNEL staining
VSMCs were plated onto eightchamber microscopy slides. Apoptosis was induced by starvation in serumfree DMEM. After 48 hours, VSMCs were fixed in 4% paraformaldehyde and then permeabilized with 0.1% Triton X100 for 10 min. TUNEL staining was performed with a TUNEL staining kit (Roche) and mounted in VECTASHIELD mounting medium with propidium iodide. Ten fields per well were analyzed at 20× using a Zeiss LSM 510 microscope. Data are presented as a percentage of TUNELpositive nuclei to total number.
Cytosolic Ca
2+ imaging Cells cultured on glassbottomed tissue culture dishes were washed once with normal Tyrode's buffer and incubated with 2.5 M Fura2 AM (Invitrogen) in loading buffer with 2% bovine serum albumin (BSA) for 20 min at room temperature. Cells were then washed twice with normal Tyrode's buffer and incubated for another 10 min at 37°C to allow for deesterification of Fura2 AM. To record the changes in cytosolic Ca 2+ transients, images were acquired continuously, from 3 min before and at least 10 min after PDGF treatment, using an Olympus IX81 Inverted Light microscope. The cells were excited alternatively at 340 and 380 nm. Fluorescence signal intensity was acquired at 510 nm. Data are presented as AUC and peak amplitude. To estimate baseline cytoplasmic Ca 2+ levels, two adjacent chambers were created on a glass bottom microwell dish by applying a divider of vacuum grease. Then, VSMCs transfected with MCU siRNA or scrambled control were seeded in the two chambers without mixing the two cell preparations. Fura2 AM imaging was performed as de scribed above.
Ca
2+ retention assay Calcium Green5N was used to monitor extramitochondrial Ca 2+ in digitoninpermeabilized cultured skin fibroblasts. Recordings of mitochondrial Ca 2+ uptake were performed in a 96well plate with 100 l of respiration buffer [100 mM K aspartate, 20 mM KCl, 10 mM Hepes, 5 mM glutamate, 5 mM malate, and 5 mM succinate (pH 7.3)] supplemented with 100 M blebbistatin, 5 M thapsigargin, 0.005% digitonin, and 1 M Calcium Green5N (Invitrogen). Calcium Green 5N fluorescence was monitored at 485nm excitation and at 535nm emission after adding CaCl 2 (100 M free Ca 2+ at 30°C). FCCP was added at a concentration of 25 M. 4) with NaOH). Imaging was performed at room temperature with a Leica TCS SP8 STED confocal microscope. Pericam was excited at 405 and 480 nm, and its emission was recorded at 535 nm. ATP (100 M) or PDGF (20 ng/ml) was added by micropipet (in amounts of 10 l) to trigger mitochondrial Ca 2+ uptake. Recordings were performed every 5 s for at least 10 min. mtPericam signals were quantified by ImageJ. The rise in amplitude above baseline and the AUC for 5 min after PDGF application were calculated. Peak amplitude (R) was calculated using R peak − R baseline . The AUC was determined by subtracting the AUC at the baseline ratio. Summary data represent the average dif ference in basal and peak mitochondrial [Ca 2+ ].
Adenoviral transduction
Cell cycle analysis
VSMCs transfected with MCU siRNA or scramble or WT and MCU −/− skin fibroblasts were grown to confluence, maintained in a postcon fluent state for 48 hours, and then split to 50% density. DMEM with 10% FBS was added for the indicated times (24 and 32 hours for VSMCs and 16 and 24 hours for skin fibroblasts). For some experiments, treatment with aphidicolin (2 g/ml) for 24 hours was used to arrest skin fibroblasts at the G 1 S cell cycle transition. After 24 hours, cells were washed with PBS and cultured in DMEM with 10% FBS and PDGF (20 ng/ml) for 5 hours. The cells were harvested, fixed with 75% icecold ethanol, stained with propidium iodide (stock solution of 50 g/ml), and analyzed in an LSRII Flow Cytometer (Becton Dickinson).
Cell lysis and fractionation
For wholecell lysates, cells were lysed in radioimmunoprecipitation assay buffer [20 mM tris, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% Triton X100, 0.5% deoxycholate, and 0.1% SDS (pH 7.4) sup plemented with protease (Mini cOmplete, Roche) and phosphatase inhibitors (PhosSTOP, Roche)]. Lysates were sonicated, and debris were pelleted by centrifugation at 10,000g for 10 min at 4°C. For mitochondrial fraction preparation, cells were washed in PBS and in MSEM buffer (5 mM Mops, 70 mM sucrose, 2 mM EGTA, and 220 mM Mannitol (pH 7.5) with protease inhibitors] before homog enization in cold MSEM buffer using 50 strokes in a PotterElvehjem glass Teflon homogenizer. Nuclei and cell debris were pelleted by centrifugation at 600g for 5 min at 4°C. Mitochondria were separated from the cytosolic fraction by centrifugation at 8000g for 10 min at 4°C. Protein concentrations were determined by Pierce BCA protein assay (Thermo Fisher Scientific).
Immunoblotting
Equivalent amounts of protein (5 to 15 g) were separated on NuPAGE 4 to 12% bistris gels (Life Technologies) and transferred to polyvinyl difluoride membranes (BioRad). Membranes were blocked in 5% BSA and incubated overnight at 4°C with primary antibodies. Blots were washed three times for 10 min with 0.05% Tween 20 in tris buffered saline and incubated for 1 hour at room temperature with the secondary antibodies at a dilution of 1:5000 to 1:15,000. Blots were developed with enhanced chemiluminesent (ECL) substrate, scanned, and analyzed using ImageJ software.
Confocal microscopy
For immunofluorescence imaging, cells were grown on coverslips precoated with 0.1% gelatin. Mitochondria were labeled by trans duction with adenovirus expressing mtGFP for 48 hours or loading with 200 nM MitoTracker Deep Red at 37°C for 30 min, fixed in 4% paraformaldehyde, and permeabilized with 0.1% Triton X100 in PBS. Cells were blocked in blocking buffer (1× PBS with 2% glycerol, 50 mM ammonium chloride, 5% FBS, and 2% goat serum). Rabbit antiDrp1 antibody was applied at 1:100 in blocking buffer over night at 4°C. After rinsing three times in PBS, goat antirabbit sec ondary antibody (1:2000; Alexa Fluor 568) was applied for 1 hour at room temperature. Cells were mounted in VECTASHIELD mount ing medium with 4′,6diamidino2phenylindole (DAPI). Images were acquired using a Zeiss LSM 510 confocal microscope equipped with a 63× oil immersion objective, excited with an argon laser at 488 nm filtered with NFT490 and BP505530 Zeiss filters and with a HeNe laser at 543 nm (NFT565/BP575615) and controlled by ZEN soft ware (Zeiss). Colocalization of Drp1 with mitochondria was quan tified as the Pearson's coefficient using the JaCoP plugin for NIH ImageJ software.
Mitochondrial morphology quantification
Mitochondrial fission and fusion were determined in VSMCs trans duced with adenovirus expressing mtGFP (MOI of 50) for 48 hours. For automated morphometry, images were processed using NIH ImageJ software, with the plugins involving either "rolling ball" background subtraction or deblurring by twodimensional decon volution with a computed point spread function. Using a customwritten NIH ImageJ macro provided by S. Strack (University of Iowa), pro cessed images were converted to binary (black and white) images by autothresholding, and mitochondrial particles were analyzed for length or form factor [perimeter 2/(4 ×  × area)] (47, 48) . The pa rameters for form factor are set with a minimum value of 1 for per fectly circular mitochondria.
Assessment of bioenergetics
OCR was monitored with the ESA BioStat Multi Electrode System (ESA Products, Dionex Corporation) in conjunction with a YSI Oxygen Probe (5331) and glass reaction chamber vials in a YSI bath assembly (5301, Yellow Springs Instruments), all at room temperature. Cells were suspended in Hanks' balanced salt solution media at a density of 1 × 10 6 to 3 × 10 6 cells per 1 ml; the typical sample size was 2 ml. For experiments in the Seahorse XF Analyzer, VSMCs were plated onto a 96well Seahorse plate at a density of 20,000 per well, 24 hours before the experiment. The cells were equilibrated in Seahorse assay medium (unbuffered DMEM) for 1 hours. PDGF (20 ng/ml) was added immediately before the assay in a Seahorse Bioscience XF96 analyzer. Oligomycin, FCCP, and antimycin/rotenone were added to some wells at concentrations of 1, 1.5, and 2 M, respectively. Total ATP, ADP (adenosine 5′diphosphate), and AMP (adenosine 5′monophosphate) were determined with the AMPGlo Kit (V5011, Promega Corporation) in 10 g of total cell lysates. All measure ments were performed in triplicates. Lactate levels were measured with the Lactate Analyzer (Lactate Scout, EKF Diagnostics) with Lactate Scout Test Strips (code 55). A standard curve was estab lished from 0.5 to 5 mM with sodium lactate in cell culture medium with 10% FBS. Skin fibroblasts were grown to 90% confluency, serum starved for 24 hours, and then grown in medium with 10% FBS for 16 hours. Cells were trypsinized, counted, and lysed in hypotonic lysis buffer. Lactate concentrations were normalized to cell numbers.
P110 peptide delivery
Chariot was used for intracellular delivery of the peptide P110 (syn thesized by GenScript) based on the manufacturer's protocol. The transfection mixture of 100 l of OptiMEM, 5 l of Chariot, and P110 (2 mM) was mixed and incubated at room temperature for 30 min and then was added to VSMCs in a final volume of 1 ml for 1 hour before the experiment.
Materials
The following reagents were purchased from Thermo Fisher Scientific: thapsigargin (T7459), recombinant mouse PDGFBB (PMG0044), MitoSOX Red (M36008), DharmaFECT 4 reagent (T200402), and Fura2 AM (F1221). The TUNEL staining kit (#12156792910) was bought from Roche. Aphidicolin was purchased from SigmaAldrich (A4487). To increase intracellular Ca 2+ , we applied ATP (A300030, Research Product International Corp.) and caffeine (#C0750, Sigma Aldrich). RU360 (#557440, Calbiochem) was applied as a phar macological inhibitor of MCU. To visualize mitochondria or the mitochondrial membrane potential, we used MitoTracker Deep Red (M22426, Life Technologies) or tetramethylrhodamine, methyl ester (34361, Invitrogen), respectively. The Drp1 inhibitor peptide P110TAT was synthesized by GenScript and delivered with the protein delivery reagent Chariot from Active Motif (#30025). MOM and VECTASHIELD kits with DAPI or propidium iodide were pur chased from Vector Laboratories. The watersoluble CaMKII inhibitor KN93 was purchased from Calbiochem/EMD Millipore (422711). For dissociation of the skin or aorta, collagenase type II (4174) and collagenase type I (4194) from Worthington Biochemical Corpora tion were used. The antiCaMKII antibody used for Western blots was purchased from EMD Millipore (N terminus, #071496). Anti phospho CaMKII (Thr 287 , #12716), antiphospho pDRP1 (Ser 616 , D9A1, #4494), antiDRP1 (D6C7, #8570), anticyclin D (#2229S), antiCoxIV (#4850S), antiGAPDH (#2178), antipSer PKC phospho rylation targets (#2261), and antimouse immunoglobulin G (IgG)-HRP (#7076S) antibodies were purchased from Cell Signaling Technology. Antirabbit IgGHRP (#1706515) was acquired from BioRad, and antiMCUA antibody (HPA016480, Prestige Anti bodies), antiEMRE (HPA060340), antiNCLX (SAB2102181), and antiMICU1 (HPA037480) were purchased from SigmaAldrich. AntiMCUB was purchased from Abgent (C109B, AP12355b). Anti PCNA monoclonal antibody was from Invitrogen (133900). Anti cyclin E (sc481) and the ECL reagent were purchased from Santa Cruz Biotechnology (sc2048).
Statistical analysis
All data are presented as means ± SEM. Normal distribution was es tablished by D'AgostinoPearson omnibus normality test. Differences within and between groups were tested for significance by oneway ANOVA, followed by the Tukey post hoc test or by an unpaired t test (GraphPad Prism 7.0). For paired samples, an analysis by Wilcoxon matchedpairs signed rank test was performed. Repeated measures twoway ANOVA was performed for growth curves and measure ments of wound size. When normal distribution was absent, a Kruskal Wallis or MannWhitney U test was performed. A P value of less than 0.05 was considered statistically significant.
SUPPLEMENTARY MATERIALS
stke.sciencemag.org/cgi/content/full/12/579/eaav1439/DC1 Fig. S1 . MCU −/− mice demonstrate postnatal growth retardation. 
